Bottom line: Patients with resectable non-small cell lung cancer (NSCLC) who were treated with neoadjuvant nivolumab had improved five-year recurrence-free ...
The wildfire season is off to an unprecedented start across Canada, with significant fires raging out-of-control in regions across the...
Read moreThe Verge has an interesting scoop, Apple has acquired Mira, the Los Angeles-based augmented reality (AR) startup. Known for manufacturing...
Read moreDespite centuries of taboo and titillation, masturbation in primates appears to serve an evolutionary purpose. A study published June 6...
Read morePre-term and low birthweight infants have fewer fractures in childhood than full-term and normal-weight newborns, according to a new a...
Read more
© Hospital News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
